https://www.selleckchem.com/pr....oducts/epz004777.htm
In an institutional biopsy review study we noted an increase in GP5 diagnosis over time which could not be attributed to the adoption of new GP5 sub-patterns or to overdiagnosis, but might be associated with changing biopsy indications. Further studies on the prognostic impact of GP5 sub-patterns and their molecular genetic profile are indicated.Nerve growth factor (NGF) and its receptors, the neurotrophic receptor tyrosine kinase 1 (NTRK1/TrkA) and the common neurotrophin receptor (NGFR/p75NTR), are increasingly implicated in cancer
Like
Comment
Share
